Dr Michele Sale, PhD

Dr Sale aims to identify and characterize genetic contributors to complex disease susceptibility. She is the co-PI of GARNET (the Genomics and Randomized Trials Network) grant using participants from the Vitamin Intervention for Stroke Prevention (VISP) trial to identify genetic variants associated with recurrent ischaemic stroke and combined vascular endpoints, gain insights into individual responses to vitamin B therapy, and develop predictive models of recurrent stroke, incorporating clinical and genetic information. She also uses a genome-wide association study approach to identify and characterize genetic variants that contribute to type 2 diabetes susceptibility in African American Sea Islanders of coastal South Carolina and Georgia and identify variants contributing to lipoprotein subclasses - predictors of cardiovascular outcomes - measured using nuclear magnetic resonance (NMR). She is a collaborator with the REGARDS and MESA studies. She is an associate editor for Frontiers in Applied Genetic Epidemiology.